Saturday, November 27, 2021

Health

BioBiz: Immusoft inks deal with Takeda Pharma; Affyimmune closes $30M Series A Funding

Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential value of more than $900 million, to discover, develop and commercialize transformative cell therapies in rare inherited metabolic disorders with...

WHO recommends groundbreaking malaria vaccine for African children at risk

The World Health Organization on Wednesday endorsed the malaria vaccine Mosquirix, the first step in a process that should lead to wide distribution in poor countries. To have a malaria vaccine that is safe, moderately effective and...

COVID-19’s Vaccine and Drug Innovators Chosen as Recipients of the Galien Foundation 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity

The Prix Galien Awards Committee announced that six world-leading biopharma companies responsible for the development of COVID-19 vaccines and therapeutics will jointly receive the 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity at the...

Pfizer’s COVID-19 vaccine to garner full FDA approval next week

According to media reports, the Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine by early next week, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s...

BioBiz: Amgen Inc received approval from The U.S. Food and Drug Administration for Lumakras

Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic...

BioBiz: Bristol Myers Squibb to Pay Up to $1.38 Billion to License Agenus’ Oncology Drug

Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38 billion. Under the licensing agreement, BMS will spearhead development and commercialization of...

Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S.

Johnson & Johnson COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization, following a decision from the United States Centers for Disease Control (CDC) and Food...

BioBiz: Johnson & Johnson COVID-19 Vaccine stopped; Repertoire gets $189M infusion; Agenus presents clinical data; Solo-Dex launches and more

Both the FDA and Centers for Disease Control have decided to stop administering Johnson & Johnson’s Covid-19 vaccine after reviewing data involving six reported cases of a rare and severe type of blood clot in individuals in...

Former President Obama cheers on Joe Biden on 11th Anniversary of Affordable Care Act

Today, behind some democrats led cheers, the focus shifted towards how the rescue plan will help Americans save in regards to their health care.

World’s first oral vaccine to fight the pandemic in the works

Researchers may have a real shot at creating an oral COVID-19 vaccine, one that can protect against variants.  A pill can be self-administered anywhere, anytime providing access to those in remote locations and the most vulnerable who...
- Advertisement -

Latest News

BioBiz: Immusoft inks deal with Takeda Pharma; Affyimmune closes $30M Series A Funding

Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential...
- Advertisement -

WHO recommends groundbreaking malaria vaccine for African children at risk

The World Health Organization on Wednesday endorsed the malaria vaccine Mosquirix, the first step in a process that should lead to wide...

COVID-19’s Vaccine and Drug Innovators Chosen as Recipients of the Galien Foundation 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity

The Prix Galien Awards Committee announced that six world-leading biopharma companies responsible for the development of COVID-19 vaccines and therapeutics will jointly...

Pfizer’s COVID-19 vaccine to garner full FDA approval next week

According to media reports, the Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine by early next week, further...

WWE® issues John Cena NFTs Leading Into SummerSlam

The WWE will create non-fungible-tokens (NFTs) inspired by WWE Superstar John Cena, along with never-before-sold memorabilia and experiences, just in time for...